Insulet (PODD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Insulet Reports First Quarter 2016 Financial Results
April 28, 2016 4:02 PM EDTBILLERICA, Mass., April 28, 2016 /PRNewswire/ -- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced financial results for the three months ended March 31, 2016.       Â
First Quarter Highlights and Recent Developments:
First quarter revenue of $81.2 million exceeds the Company's guidance of $77 to $80 million and represents year-over-year growth of 69%. U.S. OmniPod revenue of $50.7 million, an increase of 28%. International OmniPod revenue of $15.4 million, an increase of 307%. Drug Delivery revenue of $15.1... More